Skip to main content

Oosthuizen Johannes Jacobus's Form 4 filing

Merck & Co., Inc. (MRK) · filed Feb 5, 2024

Accession no.
0001127602-24-003352
Filed
Feb 5, 2024
Trade date
Feb 2, 2024
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.41M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Oosthuizen Johannes JacobusCIK 0001916310Officer (President, U.S. Market)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseAcquired+6,773$75.36+$510,413.2828,122.35Direct
Feb 2, 2024Common StockMOption exerciseAcquired+7,045$73.73+$519,427.8535,167.35Direct
Feb 2, 2024Common StockMOption exerciseAcquired+7,119$87.10+$620,064.942,286.35Direct
Feb 2, 2024Common StockSSaleDisposed−18,959$127.18−$2,411,205.6223,327.35Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseDisposed−6,773$0.00$00Direct
Feb 2, 2024Common StockMOption exerciseDisposed−7,045$0.00$07,049Direct
Feb 2, 2024Common StockMOption exerciseDisposed−7,119$0.00$014,240Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)